Intravascular delivery of mycophenolic acid
US6471980B2 · kind B2 · utility
207Cited by
101References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 2001 |
| Grant date | Oct 29, 2002 |
| Priority date | — |
| Expiry date | Mar 12, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/602
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The present invention provides improved devices and methods for minimizing and/or inhibiting restenosis and hyperplasia after intravascular intervention. In particular, the present invention provides luminal prostheses which allow for programmed and controlled mycophenolic acid delivery with increased efficacy to selected locations within a patient's vasculature to inhibit restenosis. An intraluminal delivery prosthesis may comprise an expansible structure and means on or within the structure for releasing mycophenolic acid at a rate selected to inhibit smooth muscle cell proliferation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.